Skip to main content
Priscilla Brastianos, MD, Oncology, Boston, MA

PriscillaKaliopiBrastianosMD

Oncology Boston, MA

Hematologic Oncology, Neuro-Oncology

Director, Central Nervous System Metastasis Program, Massachusetts General Hospital, Harvard Medical School

Dr. Brastianos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Brastianos' full profile

Already have an account?

  • Office

    55 Fruit St
    # Massachu
    Boston, MA 02114
    Phone+1 617-724-4000

Summary

  • Dr. Priscilla Brastianos is an oncologist in Boston, MA and is affiliated with Massachusetts General Hospital (MGH). She is Director of the CNS Metastasis Center at MGH. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice 11 years.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2006
  • University of British Columbia
    University of British ColumbiaB.S., Biochemistry and Chemistry, 1998 - 2002

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2022 - 2026
  • RI State Medical License
    RI State Medical License 2022 - 2026
  • FL State Medical License
    FL State Medical License 2022 - 2025
  • MA State Medical License
    MA State Medical License 2009 - 2025
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Jayne Koskinas Memorial Lecture Jayne Koskinas Ted Giovanis Foundation for Health and Policy and Leadership, 2019
  • Harvard Medical School Teaching Award 2018
  • University of Alberta CRINA lectureship Canadian Neuro-Oncology Meeting, 2018
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Toward Precision Medicine in Brain Metastases  
    Priscilla Brastianos, MD, Thieme
  • The Dual PI3K/mTOR-pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA-Mutant Breast Cancer Brain Metastases  
    Priscilla K Brastianos, Daniel P Cahill, Clinical Cancer Research
  • DMD Genomic Deletions Characterize a Subset of progressive/higher-grade Meningiomas with Poor Outcome  
    Ganesh M Shankar, Sandro Santagata, Priscilla K Brastianos, Daniel P Cahill, Acta Neuropathologica
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Genetic characterization demonstrates high frequency of clinically actionable mutations in SMO and AKT1 in skull base meningiomas
    Brastianos, P.K., Society for Neuro-Oncology International Meningioma Meeting, Toronto, ON, Canada, 1/1/2016
  • Genomic Characterization of Brain Metastases Reveals Branched Evolution and Metastasis-specific Mutations
    Brastianos, P.K., Clonal Evolution Symposium, AACR National Meeting, Philadelphia, PA, 1/1/2015
  • Modes of metastasis in human and murine cancer revealed by whole exome sequencing
    Carter, S.L., Brastianos, P.K., Mcfadden, D.G., Papagiannokopoulos, T., Taylor-Weiner, A., Cibulskis, K., Jacks, T., Hahn, W.C., Getz, G, American Association for Cancer Research, San Diego, CA, 1/1/2014
  • Join now to see all

Lectures

  • Will There Ever Be Progress for Leptomeningeal Carcinomatosis: An Update on the Multidisciplinary... 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/4/2019
  • How Can We Apply Precision Medicine to Craniopharyngioma and Meningioma? 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Phase II study of pembrolizumab in leptomeningeal carcinomatosis. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
  • Join now to see all

Other

  • Identification of PIN1 inhibitors as possible therapeutic agents against Alzheimer’s disease (Thesis) 
    Brastianos, P.K, University of British Columbia
    1/2/2002

Authored Content

  • Brain Metastasis from Squamous Cell Carcinoma of the Head and Neck: A Review of the Literature in the Genomic Era RelatedJune 2018

Press Mentions

  • World Cancer Research Day: How MGH Research Scholars Are Helping to Move the Field Forward
    World Cancer Research Day: How MGH Research Scholars Are Helping to Move the Field ForwardSeptember 24th, 2024
  • Kazia Launches New Scientific Advisory Board Comprised of World-Leading Experts in Brain Cancer
    Kazia Launches New Scientific Advisory Board Comprised of World-Leading Experts in Brain CancerJuly 12th, 2022
  • Phase Ii Study of Paxalisib in Brain Metastases Advances to Expansion Stage in Breast Cancer Brain Metastases Cohort
    Phase Ii Study of Paxalisib in Brain Metastases Advances to Expansion Stage in Breast Cancer Brain Metastases CohortJune 7th, 2022
  • Join now to see all

Professional Memberships